|
[1] Bonner-Weir S, Inada A, Yatoh S, et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans,2008,36(Pt 3):353-356.
[2] Mihm S. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes. Dig Dis,2010,28(1):280-284.
[3] Lik Sprava. Oxidative stress in patients with type I diabetes mellitus and persistent coxsackie virus B infection as the reason of dysfunction of the immune system.Lik Spraua,2009(7-8):11-14.
[4] Docherty K. Pancreatic stellate cells can form new beta-like cells. Biochem J, 2009,421(2):e1-4.
[5] Ryan E A, Lakey J R, Paty B W, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes,2002,51(7):2148-2157.
[6] Takahashi K, Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell,2006,126(4):663-676.
[7] Ahlgren U, Jonsson J, Jonsson L, et al.Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev,1998,12(12):1763-1768.
[8] Noguchi H. Production of pancreatic beta-cells from stem cells. Curr Diabetes Rev,2010,6(3):184-190.
[9] Lavon N, Yanuka O, Benvenisty N. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells,2006,24(8):1923-1930.
[10] Zhou J, Pineyro M A, Wang X, et al. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta a transcription factors. J Cell Physiol,2002,192(3):304-314.
[11] Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1(1-37) converts intestinal epithelial cells into insulin-producing cell. Proc Natl Acad Sci USA,2003,100(9):5034-5039.
[12] Nakajima-Nagata N, Sakurai T, Mitaka T, et al. In vitro induction of adult hepatic progenitor cells into insulin-producing cells. Biochem Biophys Res Commun,2004,318(3):625-630.
[13] Meglasson M D, Matschinsky F M. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev. 1986,2(3-4):163-214.
[14] Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes, 1996,45(11):1478-1488.
[15] O’Brien T D, Westermark P, Johnson K H. Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas. Biochem Biophys Res Commun, 1990,170(3):1223-1228.
[16] Park J Y, No H S, Ahn Y R, et al. Pathologic changes and glucose homeostasis according to expression of human islet amyloid polypeptide in type 2 diabetic patients. J Histochem Cytochem,2010,58(8):731-740.
[17] Clark A, Nilsson M R. Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? Diabetologia,2004,47(2):157-169.
[18] Miyatsuka T, Kosaka Y, Kim H, et al. Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a. Proc Natl Acad Sci USA,2011,108(1):185-190.
[19] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature,2008,455(7213):627-632.
[20] Zhao M, Amiel S A, Ajami S, et al. Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS One,2008,3(7):e2666.
[21] Naya F J, Huang H P, Qiu Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Gene Dev, 1997,11(18):2323-2334.
[22] Smith S B, Ee H C, Conners J R, et al. Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol Cell Biol, 1999,19(12):8272-8280.
[23] Oliver-Krasinski J M, Stoffers D A. On the origin of the beta cell. Genes Dev,2008,22(15):1998-2021.
[24] Spence J R, Wells J M. Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells. Dev Dyn,2007,236(12):3218-3227.
[25] Liu G L, Lu Y F, Li W J, et al. Differentiation of marrow-derived islet-like cells and their effects on diabetic rats. Chin Med J (Engl). 2010,123(22):3347-3350.
[26] Karaoz E, Ayhan S, Okcu A, Aksoy A et al. Bone marrow-derived mesenchymal stem cells co-cultured with pancreatic islets display β cell plasticity. J Tissue Eng Regen Med,in Press.
[27] Phuc P V, Nhung T H, Loan D T, et al. Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cell Dev Biol Anim,in Press.
[28] Noguchi H, Matsumoto S, Ueda M, et al. Method for isolation of mouse pancreatic stem cells. Transplant Proc,2008,40(2):422-423.
[29] Yatoh S, Dodge R, Akashi T, et al. Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes,2007,56(7):1802-1809.
[30] Li X Y, Zhan X R, et al. CREB is a regulatory target for the protein kinase Akt/PKB in the differentiation of pancreatic ductal cells into islet β-cells mediated by hepatocyte growth factor. Biochem Biophys Res Commun,in Press.
[31] Lardon J, Huyens N, Rooman I, et al. Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch, 2004,444(1):61-65.
[32] D’Amour K A, Bang A G, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol,2006,24(11):1392-1401.
[33] D’Amour K A, Agulnick A D, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 2005,23(12):1534-1541.
[34] Borowiak M, Maehr R, Chen S, et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell,2009,4(4):348-358.
[35] Kroon E, Martinson L A, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol, 2008,26(4): 443-452.
[36] Kumar M, Jordan N, Melton D, et al. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev Biol,2003,259(1):109-122.
[37] Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Scinece,2001,292(5520):1389-1394.
[38] Ibii T, Shideaki H, Miura M, et al. Possibility of insulin-producing cells derived from mouse embryonic stem cells for diabetes treatment. J Biosci Bioeng, 2006, 103(2): 140-146.
[39] Liu H, Xue W J, Fen X S, et al. Differentiation of insulin-producing cells from mice embryonic stem cells R1. Sciencepaper Online,2009.
[40] Fujikawa T, Oh S H, Pi L, et al. Teratoma formation leads to failure of treatment of type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol,2005,166(6):1781-1791.
[41] Zhao X Y, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature,2009,461(7260):86-90.
[42] Masip M, Veiga A, Izpisua J C, et al. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation. Mol Hum Reprod,2010,16(11):856-868.
[43] Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell,2010,7(1):11-14.
[44] Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res,2009,19(4):429-438.
|
